Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis.
about
Homeostasis and inflammation in the intestineHorror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)Function of Nod-like receptors in microbial recognition and host defenseRole of regulatory T cell in the pathogenesis of inflammatory bowel diseasePattern Recognition Receptors in Cancer Progression and MetastasisRoles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseasesNOD-Like Receptors: Master Regulators of Inflammation and CancerThe TNBS-induced colitis animal model: An overviewHolding the inflammatory system in check: NLRs keep it coolNLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signalingA functional role for Nlrp6 in intestinal inflammation and tumorigenesisPeptidoglycan recognition proteins protect mice from experimental colitis by promoting normal gut flora and preventing induction of interferon-gammaInflammatory bowel diseaseToll-like receptor 2 (TLR2)-TLR9 crosstalk dictates IL-12 family cytokine production in microglia.NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis.Evidence for impaired CARD15 signalling in Crohn's disease without disease linked variants.Interactions between the host innate immune system and microbes in inflammatory bowel disease.The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis.Pathogen recognition receptors, cancer and inflammation in the gut.Uncovering Pathogenic Mechanisms of Inflammatory Bowel Disease Using Mouse Models of Crohn's Disease-Like Ileitis: What is the Right Model?Staphylococcal peptidoglycan co-localizes with Nod2 and TLR2 and activates innate immune response via both receptors in primary murine keratinocytesImmune responses upon Campylobacter jejuni infection of secondary abiotic mice lacking nucleotide-oligomerization-domain-2.NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathwayNod2 suppresses Borrelia burgdorferi mediated murine Lyme arthritis and carditis through the induction of tolerance.Molecular control of steady-state dendritic cell maturation and immune homeostasis.NOD-like receptors in intestinal homeostasis and epithelial tissue repair.Nucleotide-binding oligomerization domain-2 inhibits toll-like receptor-4 signaling in the intestinal epithelium.The IL18RAP region disease polymorphism decreases IL-18RAP/IL-18R1/IL-1R1 expression and signaling through innate receptor-initiated pathwaysToll-like receptors in inflammatory bowel diseases: a decade later.Intestinal epithelial cells in inflammatory bowel diseases.Peptidoglycan recognition protein 3 and Nod2 synergistically protect mice from dextran sodium sulfate-induced colitisNucleotide-binding oligomerization domain 2 and Toll-like receptor 2 function independently in a murine model of arthritis triggered by intraarticular peptidoglycanNucleotide-binding oligomerization domain-containing protein 2 controls host response to Campylobacter jejuni in Il10-/- mice.Nod2: a key regulator linking microbiota to intestinal mucosal immunity.A TNFSF15 disease-risk polymorphism increases pattern-recognition receptor-induced signaling through caspase-8-induced IL-1.Activation of pattern recognition receptors up-regulates metallothioneins, thereby increasing intracellular accumulation of zinc, autophagy, and bacterial clearance by macrophagesGenetic deletion of dectin-1 does not affect the course of murine experimental colitis.NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6.Genes and environment: how will our concepts on the pathophysiology of IBD develop in the future?Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?
P2860
Q24613509-696D3A9D-2CF9-4395-8D18-179C4CB53474Q24631660-542A8770-B4D5-444C-9A43-1AD035E5293CQ24647448-29272080-A064-4C6A-8229-C67D3DA659AFQ26768560-7A641317-A3C5-47B4-BAE6-0364BFA45A0BQ26798034-358D86AA-8558-4E1B-A7CB-76329B74B490Q26864035-53BADCB7-844E-4647-A09B-FF9855599632Q26865199-BBDE9D10-D6D5-44AA-A6F1-44065E5DE39DQ28077599-E2C151B7-086B-4A34-8538-2A794228B3C4Q28081065-E8B0ACD7-535C-4BE6-A02B-30D60ADAAD9EQ28505592-C41F3775-849D-4FC5-B731-562FBB901853Q28508154-A0CF437E-0FD1-4AC6-8217-C8DC543BDCCDQ28587904-D151E0CD-1BB7-4DB1-BBA6-4C235B2AA223Q29616286-93E513D8-70E8-4905-94AF-69F8A2857361Q30423121-B0DAF1D3-623B-4562-BB84-88FCFBFAC514Q30497993-3EA60438-E48D-46DB-90C1-99E1640359ACQ30882927-63C75D0C-8E40-444C-94AA-1A69DC75BA93Q33554402-68213E02-6EF4-4F49-ADBC-E7104A04FA28Q33583832-5872B8E3-FC56-41A2-9A5B-2BEB6BDE3A75Q33680511-F8F34F04-C12B-437B-A93F-C6041C5E3CEFQ33711741-98DB553D-020A-4419-8E15-64001C4406CDQ33719311-BBBD1B9E-DDCA-4DFE-B07C-64B4D912EA8DQ33771702-42F1D4C9-CB0C-433A-B60A-8F501FC567F0Q33815718-CBEC21CA-3A6C-4B26-BE5A-086E43A84632Q33841037-7BD7D334-F82B-4CEB-84E5-0D17A777E36FQ33882051-352BF015-CC67-42ED-8EB8-54E22C688BEDQ33907548-636E91A1-5F7E-4E81-8B8C-DE61D7B3168CQ34091864-22193955-E9FE-4E08-8048-8F71E6CA4822Q34097022-0659521C-F420-498E-953B-6B6DB327BCDAQ34134813-F3B38F41-9F9A-4468-9C51-2DF884B95AAEQ34136264-20FA9838-5C4A-4153-A5EB-0128ECFBB69EQ34146736-31C3B738-4AED-4C68-89BF-079009B41383Q34154459-C297EAFB-D9EE-4800-9742-96C6B2FE40B3Q34209010-836D11D3-367A-4358-B300-DBC679325D97Q34210133-46EE1BD8-0869-473A-92D1-2A176236056BQ34218146-EF5F58EF-5434-47C6-978E-0FAF3A1052D1Q34218985-FD1B2C5C-B5E7-457F-880E-CEAC9C828A76Q34234483-45FC3F99-75A0-4A09-8164-E8F2D41E0F03Q34253078-BA7ED2FE-1789-4EEA-AD47-C26E2E32D312Q34307355-8B39833B-C6B9-46EA-B199-39A797DE6665Q34407175-47B2B189-6BB3-4D56-90BC-64659BDFFCC7
P2860
Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Muramyl dipeptide activation o ...... ice from experimental colitis.
@ast
Muramyl dipeptide activation o ...... ice from experimental colitis.
@en
type
label
Muramyl dipeptide activation o ...... ice from experimental colitis.
@ast
Muramyl dipeptide activation o ...... ice from experimental colitis.
@en
prefLabel
Muramyl dipeptide activation o ...... ice from experimental colitis.
@ast
Muramyl dipeptide activation o ...... ice from experimental colitis.
@en
P2093
P2860
P356
P1476
Muramyl dipeptide activation o ...... mice from experimental colitis
@en
P2093
Atsushi Kitani
Ivan J Fuss
Keiko Ozato
Peter J Murray
Prafullakumar Tailor
Tomohiro Watanabe
Warren Strober
P2860
P304
P356
10.1172/JCI33145
P407
P50
P577
2008-02-01T00:00:00Z